Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06194799
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 752
Not applicableStudy completedNCT02192554
What this trial is testing

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Who this might be right for
Agitation Associated With Alzheimer's DiseaseAlzheimer's TypeMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 450
Large-scale testing (Phase 3)Study completedNCT00000179
What this trial is testing

Agitation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Large-scale testing (Phase 3)Study completedNCT01862640
What this trial is testing

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 433
Not applicableLooking for participantsNCT05847192
What this trial is testing

Tau Networks in Psychotic Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease With DelusionsAlzheimer Disease With Psychosis
Northwell Health 91
Large-scale testing (Phase 3)Looking for participantsNCT05980949
What this trial is testing

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 1,000
Not applicableLooking for participantsNCT06088121
What this trial is testing

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Who this might be right for
Alzheimer's DiseaseDementiaBrain Diseases+5 more
Advanced Technology & Communications 180
Testing effectiveness (Phase 2)Looking for participantsNCT06540833
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Who this might be right for
Psychotic DisordersAlzheimer Disease
Intra-Cellular Therapies, Inc. 370
Early research (Phase 1)Not Yet RecruitingNCT06793995
What this trial is testing

Effect of Food and Age on the Pharmacokinetics of LY03017

Who this might be right for
Alzheimer's Disease PsychosisParkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 26
Not applicableStudy completedNCT04113967
What this trial is testing

Efficacy of a Biodanza Program in People With Alzheimer's Disease.

Who this might be right for
Alzheimer Dementia (AD)Mental DisorderMood Disorders+1 more
Universidad de Almeria 40
Not applicableEnrolling By InvitationNCT07314190
What this trial is testing

Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder

Who this might be right for
Alzheimer DiseaseDementia With Lewy Bodies (DLB)Frontotemporal Dementia (FTD)+4 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,799
Not applicableLooking for participantsNCT04946916
What this trial is testing

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

Who this might be right for
SchizophreniaBipolar DisorderAlzheimer Disease+1 more
Hôpital le Vinatier 120
Large-scale testing (Phase 3)Study completedNCT00041678
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Post-approval studies (Phase 4)Study completedNCT01119638
What this trial is testing

Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone

Who this might be right for
AgitationPsychosisAlzheimer's Disease
Abarbanel Mental Health Center 40
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Large-scale testing (Phase 3)Study completedNCT01438060
What this trial is testing

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Who this might be right for
Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 232
Testing effectiveness (Phase 2)Study completedNCT02035553
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 181
Large-scale testing (Phase 3)Looking for participantsNCT05511363
What this trial is testing

Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 410
Post-approval studies (Phase 4)Ended earlyNCT01454453
What this trial is testing

Optimisation of Antipsychotic Drug Use in Older People

Who this might be right for
Alzheimer's DiseaseSchizophrenia
Institute of Psychiatry, London 64
Early research (Phase 1)UnknownNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Next Page